<p>Lipids, as core membrane components, energy stores, and signaling molecules, are indispensable for homeostasis; their dysregulation drives obesity, type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD). Lipid droplets (LDs), originating from the endoplasmic reticulum, are phospholipid-monolayer-enclosed organelles that dynamically interact with mitochondria and peroxisomes, buffering lipotoxicity, sequestering bioactive lipids, and facilitating enzymatic reactions—positioning them as metabolic hubs. PLIN3, a PAT family protein, uniquely regulates LD formation/stabilization andmediates mannose 6-phosphate receptor (MRP) trafficking: its dysfunction links to cancer (amplified growth factor receptor recycling), neurodegeneration (impaired α-synuclein clearance), and metabolic syndrome (hepatic cholesterol retention). This review synthesizes PLIN3’s structural features, LD-centric roles, and non-canonical MRP transport, establishing it as a critical node bridging lipid homeostasis and disease, with implications for therapeutic targeting in metabolic, oncologic, and neurodegenerative conditions.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

PLIN3: a multifaceted regulator of lipid droplet dynamics and disease pathogenesis

  • Jialu Ma,
  • Yuankang Feng,
  • Yihan Dong,
  • Dan Yue,
  • Yong Wang

摘要

Lipids, as core membrane components, energy stores, and signaling molecules, are indispensable for homeostasis; their dysregulation drives obesity, type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD). Lipid droplets (LDs), originating from the endoplasmic reticulum, are phospholipid-monolayer-enclosed organelles that dynamically interact with mitochondria and peroxisomes, buffering lipotoxicity, sequestering bioactive lipids, and facilitating enzymatic reactions—positioning them as metabolic hubs. PLIN3, a PAT family protein, uniquely regulates LD formation/stabilization andmediates mannose 6-phosphate receptor (MRP) trafficking: its dysfunction links to cancer (amplified growth factor receptor recycling), neurodegeneration (impaired α-synuclein clearance), and metabolic syndrome (hepatic cholesterol retention). This review synthesizes PLIN3’s structural features, LD-centric roles, and non-canonical MRP transport, establishing it as a critical node bridging lipid homeostasis and disease, with implications for therapeutic targeting in metabolic, oncologic, and neurodegenerative conditions.